CLINICAL TRIALS PROFILE FOR MOTEXAFIN GADOLINIUM
✉ Email this page to a colleague
Clinical Trials for motexafin gadolinium
| Trial ID | Title | Status | Sponsor | Phase | Summary |
|---|---|---|---|---|---|
| NCT00003409 ↗ | Motexafin Gadolinium Plus Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme | Completed | National Cancer Institute (NCI) | Phase 1 | RATIONALE: Radiation therapy uses high-energy x-rays to damage tumor cells. Motexafin gadolinium may increase the effectiveness of radiation therapy by making tumor cells more sensitive to radiation. PURPOSE: Phase I trial to study the effectiveness of motexafin gadolinium plus radiation therapy in treating patients who have newly diagnosed glioblastoma multiforme. |
| NCT00003409 ↗ | Motexafin Gadolinium Plus Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme | Completed | Jonsson Comprehensive Cancer Center | Phase 1 | RATIONALE: Radiation therapy uses high-energy x-rays to damage tumor cells. Motexafin gadolinium may increase the effectiveness of radiation therapy by making tumor cells more sensitive to radiation. PURPOSE: Phase I trial to study the effectiveness of motexafin gadolinium plus radiation therapy in treating patients who have newly diagnosed glioblastoma multiforme. |
| NCT00003410 ↗ | Motexafin Gadolinium With MRI-Guided Surgery in Treating Patients With High-Grade Gliomas | Completed | National Cancer Institute (NCI) | Phase 1 | RATIONALE: New imaging procedures such as the use of gadolinium texaphyrin with MRI may improve the ability to detect the extent of gliomas. PURPOSE: Phase I trial to study the effectiveness of gadolinium texaphyrin used with MRI-guided surgery in treating patients with high-grade glioma. |
| NCT00003410 ↗ | Motexafin Gadolinium With MRI-Guided Surgery in Treating Patients With High-Grade Gliomas | Completed | Jonsson Comprehensive Cancer Center | Phase 1 | RATIONALE: New imaging procedures such as the use of gadolinium texaphyrin with MRI may improve the ability to detect the extent of gliomas. PURPOSE: Phase I trial to study the effectiveness of gadolinium texaphyrin used with MRI-guided surgery in treating patients with high-grade glioma. |
| NCT00003411 ↗ | Radiation Therapy in Treating Patients With Bile Duct, Gallbladder, or Pancreatic Cancer | Completed | National Cancer Institute (NCI) | Phase 1 | RATIONALE: Radiation therapy uses high-energy x-rays to damage tumor cells. Motexafin gadolinium may increase the effectiveness of radiation therapy by making tumor cells more sensitive to treatment. PURPOSE: Phase I trial to study the effectiveness of radiation therapy plus motexafin gadolinium in treating patients with bile duct, gallbladder, or pancreatic cancer that cannot be removed surgically. |
| >Trial ID | >Title | >Status | >Sponsor | >Phase | >Summary |
Clinical Trial Conditions for motexafin gadolinium
Condition Name
Clinical Trial Locations for motexafin gadolinium
Trials by Country
Clinical Trial Progress for motexafin gadolinium
Clinical Trial Phase
Clinical Trial Sponsors for motexafin gadolinium
Sponsor Name
